View in EDS PDF Full Text

β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy.

Saved in:
Bibliographic Details
Title: β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy.
Authors: Nakagawa C; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States., Kadlera Nagaraj M; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States., Hernandez JC; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States., Uthay Kumar DB; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States., Shukla V; University of Texas MD Anderson Cancer Center, Houston, TX, United States., Machida R; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States., Schüttrumpf J; Biotest AG, Dreieich, Germany., Sher L; Department of Surgery, University of Southern California, Los Angeles, CA, United States., Farci P; Hepatic Pathogenesis Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States., Mishra L; University of Texas MD Anderson Cancer Center, Houston, TX, United States., Tahara SM; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States., Ou JJ; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States., Machida K; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States.; Southern California Research Center for Alcoholic Liver Disease and Pancreatic Disease (ALPD) and Cirrhosis, Los Angeles, CA, United States.
Source: Frontiers in immunology [Front Immunol] 2023 Sep 08; Vol. 14, pp. 1204907. Date of Electronic Publication: 2023 Sep 08 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37744383
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nakagawa+C%22">Nakagawa C</searchLink>; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Kadlera+Nagaraj+M%22">Kadlera Nagaraj M</searchLink>; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Hernandez+JC%22">Hernandez JC</searchLink>; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Uthay+Kumar+DB%22">Uthay Kumar DB</searchLink>; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Shukla+V%22">Shukla V</searchLink>; University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Machida+R%22">Machida R</searchLink>; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Schüttrumpf+J%22">Schüttrumpf J</searchLink>; Biotest AG, Dreieich, Germany.<br /><searchLink fieldCode="AU" term="%22Sher+L%22">Sher L</searchLink>; Department of Surgery, University of Southern California, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Farci+P%22">Farci P</searchLink>; Hepatic Pathogenesis Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Mishra+L%22">Mishra L</searchLink>; University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Tahara+SM%22">Tahara SM</searchLink>; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Ou+JJ%22">Ou JJ</searchLink>; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Machida+K%22">Machida K</searchLink>; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States.; Southern California Research Center for Alcoholic Liver Disease and Pancreatic Disease (ALPD) and Cirrhosis, Los Angeles, CA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2023 Sep 08; Vol. 14, pp. 1204907. <i>Date of Electronic Publication: </i>2023 Sep 08 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37744383
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2023.1204907
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1204907
    Titles:
      – TitleFull: β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nakagawa C
      – PersonEntity:
          Name:
            NameFull: Kadlera Nagaraj M
      – PersonEntity:
          Name:
            NameFull: Hernandez JC
      – PersonEntity:
          Name:
            NameFull: Uthay Kumar DB
      – PersonEntity:
          Name:
            NameFull: Shukla V
      – PersonEntity:
          Name:
            NameFull: Machida R
      – PersonEntity:
          Name:
            NameFull: Schüttrumpf J
      – PersonEntity:
          Name:
            NameFull: Sher L
      – PersonEntity:
          Name:
            NameFull: Farci P
      – PersonEntity:
          Name:
            NameFull: Mishra L
      – PersonEntity:
          Name:
            NameFull: Tahara SM
      – PersonEntity:
          Name:
            NameFull: Ou JJ
      – PersonEntity:
          Name:
            NameFull: Machida K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 09
              Text: 2023 Sep 08
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1